Hepatitis C and PIs.
In a large, retrospective analysis of HIV/HCV-coinfected patients, treatment with PI-containing regimens was associated with lower fibrosis scores and a slower progression to cirrhosis.
Albrecht
H
H
Division of Infectious Diseases, Emory University School of Medicine, Atlanta, USA.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001706:Biopsy; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006526:Hepatitis C / Q000150:complications / Q000473:pathology*; D006801:Humans; D008103:Liver Cirrhosis / Q000473:pathology / Q000517:prevention & control*; D012189:Retrospective Studies
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors